About Us

UK Edinburgh Centre.
She has published over 200 papers in peer review journals.
She received her PhD in molecular genetics from the State University of New York, Stony Brook and her Master’s in Public Health from Columbia University. After postdoctoral training in the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI, Bethesda, USA), she was promoted to tenure-track Principal Investigator at DCEG-NCI from 2008 till 2015.
Her research program is aimed at understanding the role of biomarkers in the molecular pathogenesis of NCDs with an emphasis on cancer among diverse populations. She has conducted molecular epidemiology studies across the globe including the UK, US, Poland, Ghana and Kenya.
Her international leadership, service and recognition include current member of the Scottish Government Chief Scientist Office Translational Science Grants committee; the Worldwide Cancer Research Grants committee; current member of the Breast Cancer Association Consortium; treasurer for the Molecular Epidemiology Group-UK; and former committee member of the American Association for Cancer Research (AACR) Molecular Epidemiology Groupand AACR Minority Faculty Scholar Award.

She is the Secretary General of the College of Pathologists of East Central and Southern Africa (COPECSA), the Chair of the Board of Directors of African Strategies for Advancing Pathology (https://pathologyinafrica.org/) and a member of the Steering Committee of the Lancet Commission on Diagnostics. She co-chairs the Kenya National Sample Handling guidelines and is a member of the Technical Working Group (TWG) of the Cancer Control Program in the Ministry of Health in Kenya.
Dr.Sayed’s cancer research interest has been in oncopathology specifically in breast cancer and hematolymphoid malignancies in which she has several peer reviewed publications. Her current grant is studying the genomic landscape of breast cancer in Kenya. She has been the PI in a recent validation study of breast cancer biomarkers using point of care molecular techniques and a co-investigator in an University of Oxford Grand Challenges Gates funded project for the development of a mobile application the aim of which is to assist patients locate high quality laboratory services in their vicinity. Dr. Sayed has also been involved in several funded projects aimed at improving and standardizing the practice of pathology in East Central and Southern Africa.
Among her professional affiliations, Dr. Sayed is a member of the American Society of Clinical Oncology (ASCO), an adjunct member of Adjunct Member of the United States and Canadian Academy of Pathology (USCAP) a fellow of ISN and a fellow of COPECSA.

and Cell Biology and the Director of the newly established Digital and Computational Pathology Laboratory (DCPL) at Columbia University. He is also the Director of the ABP approved Physician-Scientist Research Pathway in Pathology at CUMC. Prior to that, he was a Senior Investigator at the National Cancer Institute (NCI) and acting Deputy Scientific Director of the National Institute on Minority Health and Health Disparities, where he oversaw and directed the health disparities research of tenure track investigators, staff scientists and staff physicians. While at NIH, he extended and refocused the efforts in his lab to define and reveal how alteration and/or disruption of gene regulation contribute to cancer incidence, evolution, and outcome. This extended to quantitative profiling of antigens in patient tumor samples.
An essential and overarching goal of this effort is to translate the biological implications of these observations into principles and tenets that will have a broader impact on the molecular understanding of the disease. To accomplish this, his lab incorporates molecular, biochemical, and cell biological methodology with genome-wide bioinformatics and computational imaging technology to assemble a research portfolio that leverages multi-disciplinary translational applications, to define molecular links between race, lifestyle, the environment, and disease. At NIH, he directly mentored 28 postdoctoral fellows and 27 postbaccalaureate students. At Columbia University, his other responsibilities include overseeing the career development of multiple junior faculty in his department and affiliates. He is currently a mentor on two career development awards sponsored by NIH and the Department of Defense in support of junior faculty in his department.

since August 2019. Before joining Machakos County Government, he worked as a senior lecturer and head of the department of pathology in the School of Medicine at Mount Kenya University. He holds a Ph.D. and an MMed degree in Anatomical Pathology from Kenyatta University and Aga Khan University respectively.
His research focus is on cancer diagnostics, specifically prostate cancer. He has also participated in several projects either as principal investigator or co-investigator. He spearheaded the opening and operationalisation of The Machakos Cancer Care & Research Centre at Machakos Level 5 Hospital in September 2019. This Centre has seen a tremendous increase in the number of patients seeking cancer treatment and screening services. Screening services are meant to allow for earlier diagnosis of cancer and help reduce the current problem of most cancer cases being diagnosed at a late stage. This will hopefully improve treatment outcomes and reduce cancer mortality. He is a strong advocate of evidence-based decision making, a move that is likely to increase utilisation of research findings in decision making.

Over the last 10 years Tabither has accrued vast experience in following areas of research and program implementation; maternal, neonatal and child health, Nutrition, Sexual and reproductive health rights, behavior change communication, health management systems. In addition, Tabither has vast experience in both qualitative and quantitative research methodologies. Tabither has worked with the following organizations in various capacities; Population Council, UNFPA Somalia, Options Consulting Limited, the Royal Tropical Institute, TICAH among others.Dr. Gitau has PhD in Adolescent Health University of the Witwatersrand, Johannesburg, South Africa; Masters in Science in Epidemiology and Biostatistics, University of the Witwatersrand, Johannesburg, South Africa; Bachelor of Science, Medical Laboratory Science, University of the Eastern Africa Baraton, Kapsabet, Kenya.
Her key skills are Public Health program management, project design including proposal writing, monitoring and evaluation, quantitative and qualitative research methodologies. She has working experience in the following countries Somalia, Zimbabwe (Mutoko District), South Africa (Mpumalanga Province and Guateng Province (Soweto)) and Kenya (Garissa, Nairobi, Nakuru, Kisumu, Siaya, Wajir, Turkana, Kajiado and Thika.

/Ministry of Health where She holds responsibilities of Coordinating and ensuring implementation of plan for clinical research capacity building to perform medical research, support the Ministry of Health in streamlining research regulatory frameworks that is conducive to medical research environment, coordinate translation of health research findings into knowledge that inform evidence based policies as well as establishing strategies that attract International Pharma/Biotech industries to conduct clinical trials in Rwanda by connecting them with appropriate country resources. She has more than 8 years of experience in coordination and technical management of National Health sector research projects development, implementation and research grant writing. She is the National Focal Point of East Africa Health Research Commission Activities, a member of National Health Research Committee, member of National Steering Committee in charge of National Health Research Agenda and a member of Rwanda National Health Sector Research Technical Working Group. She has been leading different medical Research projects as a PI in Rwanda Biomedical Center. Clarisse Musanabaganwa is currently pursuing her PhD studies in Epigenetics and Bioinformatics at the university of South Florida and University of Rwanda. She holds first master’s in science of epidemiology from university of Rwanda and second master’s in Public Health from Manchester Metropolitan University/UK. She holds a bachelor’s degree in biotechnology and genetic engineering from Bangalore University/India and Post graduate diploma in Clinical Research and Pharmacovigillance.

Prior to joining Mount Kenya University, he worked at Technical University of Kenya as a lecturer in the department of Biochemistry and Biotechnology from 2009 to 2014. He had earlier worked as a high school teacher of biology under Kenya’s Teachers’ Service Commission.
He holds a PhD and a Masters degree in Molecular Medicine from Jomo Kenyatta University of Agriculture & Technology. He also holds Bachelor of Science degree in biological sciences from The University of Nairobi.
His research focus is on understanding the molecular determinants of disease including NCDS. He is currently working on breast cancer genomics in Kenya. He also supports molecular studies in drug and substance abuse. He has previously worked on polymorphisms in Plasmodium falciparum erythrocyte membrane protein 1 (Pfemp1) in malaria isolates from two malaria endemic sites in Kenya and drug resistance markers in P. falciparum.
He is currently involved in building international research collaboration to bring together research expertise to study various molecular aspects of NCDs in Kenya and Africa as a whole. He is collaboration with Dr Jonine Figueroa has on piloting of precision medicine based project focusing on breast cancer in Kenya. He is also a collaborator on breast cancer genomics project in Rwanda.

joint appointment Materials Science and Engineering at Tuskegee University. He is also Adjunct faculty at Clark Atlanta University Department of Biology and Department of Pathology at University of Alabama at Birmingham. Dr. Yates has an interest prostate and breast cancer research, particularly in African Americans. Dr. Yates has established several cell lines based models derived from African American patients that are used by many labs today to study molecular events the lead prostate cancer development and metastasis. Additionally, Dr. Yates has identified multiple biomarkers for the prediction of aggressive cancers in African Americans with prostate or breast cancer, and this has led to the development of a novel therapeutic for African American Breast, Prostate, and Pancreatic patients that is posed to enter clinical trials Dr. Yates has also received numerous research honors and awards, authored over 65 peer-reviewed publications, member of the editorial board of Scientific Reports. He has received numerous DOD and R level NIH grants in prostate and breast cancer health disparities, totaling over 25 million dollars in extramural funding. Dr. Yates is currently the Co-Director for the Transatlantic Prostate Cancer Consortium, which is focused on understanding the tumor biology in native African men in Nigeria and developing novel clinical interventions for this population. Dr. Yates is currently the principle investigator (PI) of the Research Centers at Minority Institutions (RCMI), site PI of CTSA (jointly with UAB-hub institution), and co-PI of U54 Cancer Health Disparities with Morehouse School of Medicinal and University of Alabama at Birmingham.

Purdue University, and Professor of Immunology and Microbiology at Indiana University School of Medicine, Indiana, USA. Dr. Mohammed was a Walther Cancer Institute Fellow, American Association for Cancer Research-Cancer Research Foundation of America- Prevention Research Fellow, and National Cancer Institute/National Cancer Institute, National Institute of Health fellow. Dr. Mohammed was also a two-time nominee for the American Association of Cancer Research Distinguished Lecture on the Science of Cancer Health Disparities.
Dr. Mohammed is a medical scientist that goal is to reduce the cancer health disparity among African and African American women through understanding cancer development and progression and instituting new innovative preventative and treatment strategies. Her productive and impactful collaborative research with her colleagues in the USA and Africa includes instituting approaches for early detection of breast cancer using volunteer laywomen in rural areas of Africa and the development of a point-of-care test for early detection of cervical cancer. Her basic cancer research interest includes characterizing an animal model for triple-negative breast cancer prevention and treatment and developing immunotherapeutic or immune-preventative approaches such as developing CAR-T therapy to treat breast cancer and vaccines using adenovirus vector to inhibit the progression of breast ductal carcinoma in situ (DCIS) to invasive cancer. Also, Dr. Mohammed’s laboratory conduct studies to understand the breast cancer metastatic cascade through the lymphatic system and it is the first lab to decipher the characteristics of tumor cells circulating via the lymphatic system in comparison to those circulating in the blood.
Dr. Mohammed and her African colleagues reactivated the African Organization for Research and Training in Cancer (AORTIC), which facilitates cancer awareness events as well as research and training on cancer control in Africa. Dr. Mohammed was a member of the AORTIC Executive Council (2000-2017) and was a member of the constitution and the nominating committees. Because of her applied research and engagement initiatives, Dr. Mohammed has received numerous awards for her outstanding commitment and leadership in her continuous efforts to fight cancer in Africa. Dr. Mohammed was the recipient of the 2010 Leadership in the Field of Breast Cancer and Health Awareness Award by the University of Medical Sciences and Technology Sudan, the 2011 Leading the Way in Breast Cancer Research You Made a Difference from African Women’s Cancer Awareness Association, the 2016 African Diaspora Ambassador Award by Harvard Global Health Catalyst, and the 2016 Pillar of Support Award for a Decade of Support and Personal Commitment to Stop Cancer in Africa by African First Ladies.

Australia. She is the former Sub-County Medical Officer of Health, Machakos where she was involved in non-communicable and communicable diseases prevention programs by community engagement activities and health education in the County.
Currently, she is the Head of the Cancer Care and Research Centre in Machakos County. The Center provides specialized care to cancer patients from screenings, diagnostics,and treatments to provision of palliative care. Additionally, Dr. Mweni
has been involved in different research projects to estimate the burden of different cancers affecting the population in Machakos County.
Her research focus is not only on prevention but also early detection, and treatment of cancer in order to reduce its morbidity and mortality in the Country. She is the Principal Investigator for study titled, “The burden of chronic diseases among Kenyan cancer patients: Evidence from Machakos Cancer Registry, 2013-2020”. Additionally, she is a Co-investigator in a study on assessing the burden of cancer in Machakos county titled, “Analysis of Cancer Diagnosis from 2013-2019 within Machakos County, Kenya”. Throughout her career, Dr. Mweni has been conducting research in close collaboration with colleagues and partners from different research institutions with different backgrounds and culture diversity.

He is also a Lecturer in the School of Computing and Information Technology of the University. Mr. Obonyo has hands-on experience in Hadoop Big Data platform, R and SAS statistical software, programming in Java and Python, among others; coupled with projects implementation based on Big Data Analytics and Business Intelligence; a lecturer and researcher in the fields, mostly of, Big Data, Machine Learning, Business Intelligence, and Programming; and lately completed professional training in Big Data, and Machine Learning. He is also currently engaged in active research projects relating health and technology.

at the Department of Biochemistry, School of Health Sciences, Kisii University. He is currently working on T-cell receptor repertoire analysis, T-cell homeostasis & interclonal competitiveness through a DFG (German Research Foundation) funded project under CONTROL-T consortium. He is also a member of molecular epidemiology group-Africa (MEG-Africa), a consortium investigating various aspects of breast cancer in Kenya through a NRF funded project. Previously he worked on stem cell ageing, DNA damage and screening & identification of novel ploidy regulators using shRNA and CRISPR/Cas9 techniques. He has also worked on ethnopharmacology, prospecting for novel herbal-based products with antitubercular activity (financed by IFS (grant No. F/5372-1)). He has also collaborated on ethnobotanical work targeting fight against malaria, and cancer. Sospeter is also a mentor to young scientists in Africa through initiatives such DAAD (German academic exchange service), AG-career hub, and research awake Africa initiative (RAAI). Sospeter gained his bachelor’s degree in Biomedical science and technology and master’s degree in Biochemistry from Egerton University -Kenya. He did his doctoral training at Friedrich Schiller University, Jena-Germany at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI), under DAAD/NRF scholarship and Leibniz Graduate School on Aging (LGSA) fellowship. Sospeter has published over 25 peer reviewed research articles.

Research (Bethesda, MD).
He was born in Germany and received his Master’s degree in Biochemistry from the University of Tübingen (1988) and completed his Ph.D. at the Institute of Toxicology, University of Würzburg (1992). He also earned a Master of Public Health degree (Epidemiology) from Johns Hopkins Bloomberg School of Public Health (2005). Dr. Ambs was trained in translational research as a Postdoctoral Fellow at the NCI under the mentorship of Dr. Curtis C. Harris (1992-1997). He continued his research at a biotechnology company in California and at the Aventis Genomics Center in Cambridge, Massachusetts, before returning to the NCI as a tenure-track investigator in the field of Molecular Epidemiology (2001). Ambs and his colleagues conduct integrative epidemiology studies of prostate and breast cancer and utilize translational research strategies to identify risk factors and pathways that define tumor development and progression, and the response to therapy. Their research includes discovery of biomarkers using genome-wide analysis of gene expression and evaluation of the tumor metabolome and proteome, cancer health disparity, inflammation and cancer, and the analysis of genetic variations and their association with cancer using candidate gene and genome-wide association study approaches. The group has a particular research interest in the causes of cancer health disparities. Other interests include the relationship between tobacco use and fatal prostate cancer and metabolic alterations in breast cancer as targets for therapy.
more at
https://ccr.cancer.gov/stefan-ambs

(GEB) in 2000 as a postdoctoral fellow, became a tenure-track investigator in 2006, and was appointed senior investigator upon receiving NIH scientific tenure in 2014. She received NCI Director’s Intramural Innovation Awards in 2007 and 2009. Dr. Yang serves on the editorial board for Cancer Epidemiology, Biomarkers & Prevention, and is an adjunct associate professor at the Chinese University of Hong Kong. Her research interests include the genetics of familial cutaneous malignant melanoma/dysplastic nevi syndrome and chordoma, and etiologic heterogeneity of breast cancer.
Research Interests
In her research on familial cancers—including melanoma and dysplastic nevi syndrome, and chordoma—Dr. Yang employs cutting-edge genomic technologies and novel statistical approaches to evaluate copy number and exome sequencing variants, as well as mRNA expression, miRNA expression, DNA methylation, chromatin modification, and telomere length in disease susceptibility. Most recently, Dr. Yang and her colleagues identified a rare inherited mutation in a gene involved in maintaining telomere stability in melanoma families, further supporting a role for abnormal telomeres in the development of melanoma.
In her investigation of etiologic heterogeneity of breast cancer, Dr. Yang characterizes the molecular signature of tumors using tissue microarray and integrated tumor profiling analyses to identify risk factors for specific cancer subtypes. She is leading breast cancer studies in mainland China, Hong Kong, and Malaysia to identify distinct molecular alterations in tumors and adjacent normal tissues among Asian women, and to examine the associations of these molecular changes with genetic and environmental risk factors, breast tissue composition and density, and breast cancer subtypes.
more at
https://dceg.cancer.gov/about/staff-directory/yang-rose

student at the University of Nairobi; and holds a MSc. Computer Science from the University of Nairobi and BSc (1st) Computer Science from the Catholic University of Eastern Africa, Nairobi.
Her research intrests are in Artificial Intelligence, Internet of Things, and Big Data and Data Analytics in ICT4D mostly in Health, Education, and Food Security and Safety. Elizabeth has collaborated actively with other researchers in computing and other disciplines to addressing our societal challenges.
Some of the research projects she has and is participating in are:-
· Co-Investigator: Practical and Projects Based Learning (PPBL) for IoT at the School of Computing and Information Technology, the Technical University of Kenya from May 2020 to May 2021. A Call by KENET Innovation Grants in the use of Education Technology in Engineering and Computer Science Education
· Co-PI: Analytics Dashboard for Monitoring and Surveillance of Health Service Delivery: Case of Cancer. A Multidisciplinary research grant by the National Research Fund (NRF) from July 2020 to June 2023
· Co-Investigator: Assessing the impact of measures put in place by the Kenyan government to curb the spread of Covid-19 on the provision of health services in Machakos county from May 2020 to July 2020
· ICT Consultant: Investigating the Health System’s Capacity of Kitui County in Kenya to Detect and Control Infectious Diseases of Poverty October 2018 to November 2018: Role played Data collection, conduct interviews, Design and development of the e-surveillance system, Report writing
· Research Assistant: KENET – E-readiness 2013, 2015, 2019 survey of Kenyan Universities for the Technical University of Kenya
Elizabeth received a scholarship award to attend the Grace Hopper Celebration (GHC) of Women in Computing in Orlando, Florida from 1st to 4th October 2019 and also Gandhi Smarak Nidhi Fund – Postgraduate Scholarship for her Master’s program at the University of Nairobi. She is an active member of IEEE – Membership No. 92700212; IEEE – Women in Engineering (WiE); Association of Computing Machinery (ACM) – Membership No. 4350445; Oracle Academy and IBM Skills Academy.

Physiology from the University of Eldoret, Kenya. His Bachelor’s degree was on Biochemistry from Kenyatta University, Kenya. Dr. Kamita’s research area is in cancer immunology and mechanisms used by the cancer cells to develop resistance and evade the immune system’s mechanism of response. He is also interested in cancer epidemiology and establishment of cancer registries in Kenya with an aim of having near true picture of cancer burden in Kenya. He has published his work in journalsand in conference presentations. In addition, Dr. Kamita has received scholarship awards and recognition awards in course of his career. He is an active member of the Molecular Biology Society of Japan and the Christian and Scientific Association of Kenya.

at a convenient position as the Chief Executive Officer and the Senior Consultant of the Peace and Love Hospitals in Accra and Kumasi; a specialist hospital that is championing the course of Breast Cancer management in Ghana. I am a role model and inspiration to women and society as a whole, as the first female Ghanaian General Surgeon. I also have a passion and aspiration for education, prevention, awareness creation, and treatment of breast cancer, which has earned me an honorable recognition in Ghana, Africa and globally as one of the champions advocating for the eradication of the disease.
Positions Held
Consultant Breast Surgeon
Specialist in Breast Cancer Management
C.E.O., Peace and Love Hospitals, Ghana
President and Founder, Breast Care International (BCI)President and Founder, Breast Care International (BCI) America
Chairperson, Ghana Cancer Board
Chairperson, Ghana NCD Alliance Advisory Board Member, MEALS4NCDsFmr President Elect, AORTIC
Member UICC
Medical Advisory Board Member, Direct Relief, USA
Executive member, International Breast Cancer and Nutrition (IBCN) Project Purdue University, USA
Race Chair, Susan G. Komen Ghana Race for the Cure
Executive Chair, BCI Ghana Walk for the Cure
Fmr Member, Ethics Committee IARC